Team-NB wrote a one-pager in the framework of the proposed revision of the regulatory framework applicable to medical devices and in vitro diagnostic devices on Risk-adapted surveillance, to focus scrutiny where risks are highest and reward proven compliance, thereby placing patient safety at the center.
